An Updated Evaluation of Intrathecal IgG Synthesis Markers in Relation to Oligoclonal Bands
暂无分享,去创建一个
M. Anagnostouli | L. Stefanis | A. Vakrakou | K. Patas | S. Chatzipanagiotou | F. Boufidou | G. Paraskevas | M. Evangelopoulos | Aigli G. Vakrakou
[1] A. Petersmann,et al. A New Laboratory Workflow Integrating the Free Light Chains Kappa Quotient into Routine CSF Analysis , 2022, Biomolecules.
[2] T. Berger,et al. Cerebrospinal Fluid Findings in 541 Patients With Clinically Isolated Syndrome and Multiple Sclerosis: A Monocentric Study , 2021, Frontiers in Immunology.
[3] D. Chicco,et al. The Matthews Correlation Coefficient (MCC) is More Informative Than Cohen’s Kappa and Brier Score in Binary Classification Assessment , 2021, IEEE Access.
[4] H. Reiber. Non-linear ventriculo - lumbar protein gradients validate the diffusion-flow model for the blood-CSF barrier. , 2020, Clinica chimica acta; international journal of clinical chemistry.
[5] H. Reiber,et al. Diagnostic relevance of free light chains in cerebrospinal fluid - The hyperbolic reference range for reliable data interpretation in quotient diagrams. , 2019, Clinica chimica acta; international journal of clinical chemistry.
[6] X. Montalban,et al. Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study , 2019, Multiple sclerosis.
[7] A. Ludolph,et al. CSF Free Light Chains as a Marker of Intrathecal Immunoglobulin Synthesis in Multiple Sclerosis: A Blood-CSF Barrier Related Evaluation in a Large Cohort , 2019, Front. Immunol..
[8] David H. Miller,et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria , 2017, The Lancet Neurology.
[9] C. Enzinger,et al. Prognostic value of free light chains lambda and kappa in early multiple sclerosis , 2017, Multiple sclerosis.
[10] M. Zaffaroni,et al. Cerebrospinal fluid analysis and the determination of oligoclonal bands , 2017, Neurological Sciences.
[11] A. Zeileis,et al. Quantitation of intrathecal immunoglobulin synthesis – a new empirical formula , 2016, European journal of neurology.
[12] S. Rauch,et al. Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study , 2015, Multiple sclerosis.
[13] H. Tumani,et al. Cerebrospinal Fluid Immunoglobulin Kappa Light Chain in Clinically Isolated Syndrome and Multiple Sclerosis , 2014, PloS one.
[14] S. Presslauer,et al. Kappa Free Light Chains: Diagnostic and Prognostic Relevance in MS and CIS , 2014, PloS one.
[15] D. Centonze,et al. Determination of kFLC and K Index in cerebrospinal fluid: A valid alternative to assessintrathecal immunoglobulin synthesis , 2013, Journal of Neuroimmunology.
[16] G. Csako. Isoelectric focusing in agarose gel for detection of oligoclonal bands in cerebrospinal and other biological fluids. , 2012, Methods in molecular biology.
[17] Jeffrey A. Cohen,et al. Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria , 2011, Annals of neurology.
[18] Jeffrey A. Cohen,et al. Differential diagnosis of suspected multiple sclerosis: a consensus approach , 2008, Multiple sclerosis.
[19] T. Brücke,et al. Elevated levels of kappa free light chains in CSF support the diagnosis of multiple sclerosis , 2008, Journal of Neurology.
[20] A. Rovira,et al. Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis? , 2008, Neurology.
[21] H. Link,et al. Oligoclonal bands in multiple sclerosis cerebrospinal fluid: An update on methodology and clinical usefulness , 2006, Journal of Neuroimmunology.
[22] N. Gilhus,et al. Guidelines on routine cerebrospinal fluid analysis. Report from an EFNS task force , 2006, European journal of neurology.
[23] G. Giovannonid,et al. Guidelines on routine cerebrospinal fluid analysis . Report from an EFNS task force , 2006 .
[24] S. Reingold,et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria” , 2005, Annals of neurology.
[25] D. Bernard,et al. Quantification of Immunoglobulin Free Light Chains in CerebroSpinal Fluid by Nephelometry , 2005, Journal of Clinical Immunology.
[26] Gavin Giovannoni,et al. Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement. , 2005, Archives of neurology.
[27] A. Compston,et al. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis , 2001, Annals of neurology.
[28] G. Bernardi,et al. Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. , 1994, Journal of neurology, neurosurgery, and psychiatry.
[29] H. Reiber. Flow rate of cerebrospinal fluid (CSF) — A concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases , 1994, Journal of the Neurological Sciences.
[30] J. Ernerudh,et al. Comparison of Seven Formulae and Isoelectrofocusing for Determination of Intrathecally Produced IgG in Neurological Diseases , 1992, Annals of clinical biochemistry.
[31] E. Thompson,et al. A study of immunoglobulin G in the cerebrospinal fluid of 1007 patients with suspected neurological disease using isoelectric focusing and the Log IgG-Index. A comparison and diagnostic applications. , 1990, Brain : a journal of neurology.
[32] E. Thompson,et al. Isoelectric Focusing of Cerebrospinal Fluid Immunoglobulin G: An Annotated Update , 1990, Annals of clinical biochemistry.
[33] E. Thompson,et al. Isoelectric focusing versus quantitative measurements in the detection of intrathecal local synthesis of IgG. , 1990, Clinica chimica acta; international journal of clinical chemistry.
[34] P. Forsberg,et al. An improved formula for the judgement of intrathecally produced IgG in the presence of blood brain barrier damage. , 1989, Clinica chimica acta; international journal of clinical chemistry.
[35] E. Schuller,et al. IgG synthesis within the central nervous system. Comparison of three formulas. , 1987, Archives of neurology.
[36] H. Reiber,et al. Protein transfer at the blood cerebrospinal fluid barrier and the quantitation of the humoral immune response within the central nervous system. , 1987, Clinica chimica acta; international journal of clinical chemistry.
[37] J. E. Hopper,et al. Evidence by radioimmunoassay that mitogen-activated human blood mononuclear cells secrete significant amounts of light chain Ig unassociated with heavy chain. , 1986, Cellular immunology.
[38] H. Reiber. Evaluation of IgG Synthesis in the Central Nervous System , 1980 .
[39] S. Poser,et al. Progress in Multiple Sclerosis Research , 1980, Springer Berlin Heidelberg.
[40] S. Ohman,et al. Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values. , 1977, Scandinavian journal of clinical and laboratory investigation.
[41] G. Tibbling,et al. Principles of albumin and IgG analyses in neurological disorders. III. Evaluation of IgG synthesis within the central nervous system in multiple sclerosis. , 1977, Scandinavian journal of clinical and laboratory investigation.
[42] B. Delpech,et al. [Immunochemical estimation of IgG and albumin in cerebrospinal fluid]. , 1972, Clinica chimica acta; international journal of clinical chemistry.